These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9061468)

  • 21. Studies on the mechanism of absorption of depot neuroleptics: fluphenazine decanoate in sesame oil.
    Luo JP; Hubbard JW; Midha KK
    Pharm Res; 1997 Aug; 14(8):1079-84. PubMed ID: 9279892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistence of fluphenazine in plasma after decanoate withdrawal.
    Gitlin MJ; Midha KK; Fogelson D; Nuechterlein K
    J Clin Psychopharmacol; 1988 Feb; 8(1):53-6. PubMed ID: 3351000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate.
    Midha KK; Hubbard JW; Marder SR; Hawes EM; Van Putten T; McKay G; May PR
    Psychopharmacology (Berl); 1987; 93(3):369-73. PubMed ID: 3124166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitive gas-chromatographic determination of fluphenazine in human plasma.
    Franklin M; Wiles DH; Harvey DJ
    Clin Chem; 1978 Jan; 24(1):41-4. PubMed ID: 618664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate.
    Marder SR; Hawes EM; Van Putten T; Hubbard JW; McKay G; Mintz J; May PR; Midha KK
    Psychopharmacology (Berl); 1986; 88(4):480-3. PubMed ID: 3085136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC; Kennedy NM; Gribbon D
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.
    McKane JP; Robinson AD; Wiles DH; McCreadie RG; Stirling GS
    Br J Psychiatry; 1987 Sep; 151():333-6. PubMed ID: 3322467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.
    Curry SH; Whelpton R; de Schepper PJ; Vranckx S; Schiff AA
    Br J Clin Pharmacol; 1979 Apr; 7(4):325-31. PubMed ID: 444352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic monitoring of steady-state plasma levels of the N4'-oxide metabolite of fluphenazine in chronically treated schizophrenic patients determined by a specific and sensitive radioimmunoassay.
    Aravagiri M; Marder SR; Van Putten T; Hawes EM; McKay G; Hubbard JW; Midha KK
    Ther Drug Monit; 1990 May; 12(3):268-76. PubMed ID: 2349611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
    Turbott J; Villiger J; Hunter L
    Br J Psychiatry; 1985 Apr; 146():439-42. PubMed ID: 4016448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration.
    Simpson GM; Yadalam KG; Levinson DF; Stephanos MJ; Lo ES; Cooper TB
    J Clin Psychopharmacol; 1990 Dec; 10(6):417-21. PubMed ID: 2286711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subnanogram determination of fluphenazine in human plasma by gas chromatography mass spectrometry.
    McKay G; Hall K; Edom R; Hawes EM; Midha KK
    Biomed Mass Spectrom; 1983 Oct; 10(10):550-5. PubMed ID: 6652229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-performance liquid chromatography determination of pravastatin in plasma.
    Iacona I; Regazzi MB; Buggia I; Villani P; Fiorito V; Molinaro M; Guarnone E
    Ther Drug Monit; 1994 Apr; 16(2):191-5. PubMed ID: 8009569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluphenazine decanoate. Its steady-state pharmacologic profile and relationship to tardive dyskinesia.
    Glazer WM
    Schizophr Res; 1988; 1(6):425-9. PubMed ID: 3154530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma prolactin and fluphenazine concentrations in patients receiving fluphenazine decanoate: stability over injection intervals.
    Norman TR; Marriott PF; Kimber NM; Burrows GD
    Int Clin Psychopharmacol; 1987 Oct; 2(4):299-305. PubMed ID: 3693869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluphenazine decanoate: a clinical problem?
    Inderbitzin LB; Lewine RR; Gloersen BA; Rosen PB; McDonald SC; Vidanagama BP
    Am J Psychiatry; 1989 Jan; 146(1):88-91. PubMed ID: 2563210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of selected phenothiazines in human plasma by solid-phase extraction and liquid chromatography with coulometric detection.
    Saracino MA; Amore M; Baioni E; Petio C; Raggi MA
    Anal Chim Acta; 2008 Aug; 624(2):308-16. PubMed ID: 18706338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma fluphenazine levels in patients receiving two doses of fluphenazine decanoate.
    Marder SR; Hubbard JW; Van Putten T; Hawes EM; McKay G; Mintz J; May PR; Midha KK
    Psychopharmacol Bull; 1986; 22(1):264-6. PubMed ID: 3726072
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.